Leo H. Wang

2.8k total citations
35 papers, 1.2k citations indexed

About

Leo H. Wang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Leo H. Wang has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Genetics. Recurrent topics in Leo H. Wang's work include Muscle Physiology and Disorders (17 papers), Neurogenetic and Muscular Disorders Research (9 papers) and Genetic Neurodegenerative Diseases (9 papers). Leo H. Wang is often cited by papers focused on Muscle Physiology and Disorders (17 papers), Neurogenetic and Muscular Disorders Research (9 papers) and Genetic Neurodegenerative Diseases (9 papers). Leo H. Wang collaborates with scholars based in United States, Netherlands and Sweden. Leo H. Wang's co-authors include Raymond C. Stevens, Gary J. Wedemayer, Peter G. Schultz, Phillip A. Patten, Rabi Tawil, Eugene M. Johnson, Cagri G. Besirli, Dennis Shaw, Michael D. Weiss and Seth D. Friedman and has published in prestigious journals such as Science, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Leo H. Wang

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo H. Wang United States 17 801 366 194 150 111 35 1.2k
Cathérine Ghezzi France 19 482 0.6× 563 1.5× 139 0.7× 46 0.3× 276 2.5× 95 1.5k
Avgi Mamalaki Greece 22 606 0.8× 288 0.8× 207 1.1× 118 0.8× 253 2.3× 56 1.5k
Michael M. Lai United States 21 1.1k 1.4× 463 1.3× 101 0.5× 485 3.2× 31 0.3× 46 1.9k
Mikhail V. Ovanesov United States 22 513 0.6× 86 0.2× 114 0.6× 172 1.1× 183 1.6× 57 1.6k
John R. Adair United Kingdom 16 628 0.8× 733 2.0× 266 1.4× 175 1.2× 40 0.4× 32 1.4k
Katsuo Sugita Japan 22 790 1.0× 90 0.2× 112 0.6× 151 1.0× 35 0.3× 101 1.6k
Takeshi Sugawara Japan 21 1.0k 1.3× 313 0.9× 60 0.3× 274 1.8× 20 0.2× 70 1.7k
Dong Soo Kang South Korea 15 603 0.8× 63 0.2× 106 0.5× 316 2.1× 112 1.0× 44 968
Stephen M. Kaminsky United States 28 1.1k 1.3× 125 0.3× 112 0.6× 281 1.9× 123 1.1× 83 2.1k
Pooja Naik United States 13 561 0.7× 53 0.1× 116 0.6× 104 0.7× 55 0.5× 24 1.2k

Countries citing papers authored by Leo H. Wang

Since Specialization
Citations

This map shows the geographic impact of Leo H. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo H. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo H. Wang more than expected).

Fields of papers citing papers by Leo H. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo H. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo H. Wang. The network helps show where Leo H. Wang may publish in the future.

Co-authorship network of co-authors of Leo H. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Leo H. Wang. A scholar is included among the top collaborators of Leo H. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo H. Wang. Leo H. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedman, Seth D., Leo H. Wang, Dennis Shaw, et al.. (2025). 3D finite element models reveal regional fatty infiltration modulates tibialis anterior force generating capacity in FSHD. PLoS ONE. 20(7). e0319881–e0319881.
2.
Statland, Jeffrey, Stephen J. Tapscott, Leo H. Wang, et al.. (2025). Multi-scale machine learning model predicts muscle and functional disease progression. Scientific Reports. 15(1). 25339–25339. 1 indexed citations
3.
Wong, Chao-Jen, Seth D. Friedman, Lauren Snider, et al.. (2024). Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression. Human Molecular Genetics. 33(8). 698–708. 10 indexed citations
4.
Goyal, Namita, Steven A. Greenberg, Vivian Li, et al.. (2022). Correlations of disease severity outcome measures in inclusion body myositis. Neuromuscular Disorders. 32(10). 800–805. 6 indexed citations
5.
Wang, Leo H., et al.. (2021). Diminished distal dorsal finger wrinkling in patients with sporadic inclusion body myositis. Journal of Clinical Images and Medical Case Reports. 2(4). 1 indexed citations
6.
Wang, Leo H., et al.. (2021). Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report. BMC Musculoskeletal Disorders. 22(1). 56–56. 3 indexed citations
7.
Wang, Leo H., Dennis Shaw, Anna Faino, et al.. (2021). Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy. BMC Musculoskeletal Disorders. 22(1). 262–262. 24 indexed citations
8.
Ikenaga, Chiseko, Andrew R. Findlay, Namita Goyal, et al.. (2021). Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies. Annals of Clinical and Translational Neurology. 8(3). 571–578. 22 indexed citations
9.
Wang, Leo H. & Rabi Tawil. (2020). Current Therapeutic Approaches in FSHD. Journal of Neuromuscular Diseases. 8(3). 441–451. 23 indexed citations
10.
Faino, Anna, et al.. (2020). Optimizing hand-function patient outcome measures for inclusion body myositis. Neuromuscular Disorders. 30(10). 807–814. 9 indexed citations
11.
Weihl, Conrad C., et al.. (2019). A cross-sectional study of hand function in inclusion body myositis: Implications for functional rating scale. Neuromuscular Disorders. 30(3). 200–206. 3 indexed citations
12.
Latimer, Caitlin S., et al.. (2018). Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant. Neuromuscular Disorders. 28(7). 606–609. 9 indexed citations
13.
Wang, Leo H., Seth D. Friedman, Dennis Shaw, et al.. (2018). MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD. Human Molecular Genetics. 28(3). 476–486. 84 indexed citations
14.
Wang, Leo H. & Rabi Tawil. (2016). Facioscapulohumeral Dystrophy. Current Neurology and Neuroscience Reports. 16(7). 66–66. 89 indexed citations
15.
Simonson, William, et al.. (2015). Utility of Paraneoplastic Antibody Testing in the Diagnosis of Motor Neuron Disease. Journal of Clinical Neuromuscular Disease. 17(2). 63–68. 6 indexed citations
16.
Wang, Leo H., Robert C. Bucelli, Dhanashree Rajderkar, et al.. (2012). Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease. Journal of Neurology. 260(2). 498–506. 29 indexed citations
17.
Gardner, Robert B., Leo H. Wang, Andria L. Ford, & Salah Keyrouz. (2008). Spontaneous Cerebral Air Embolism Associated with Remote Lung Surgery. Neurocritical Care. 8(3). 434–436. 1 indexed citations
18.
Wang, Leo H., et al.. (2005). Mixed-Lineage Kinase Inhibitors Require the Activation of Trk Receptors to Maintain Long-Term Neuronal Trophism and Survival. Journal of Pharmacology and Experimental Therapeutics. 312(3). 1007–1019. 25 indexed citations
19.
Leitner, Melanie, Leo H. Wang, Patricia A. Osborne, et al.. (2004). Expression and function of GDNF family ligands and receptors in the carotid body. Experimental Neurology. 191. S68–S79. 21 indexed citations
20.
Wedemayer, Gary J., Leo H. Wang, Phillip A. Patten, Peter G. Schultz, & Raymond C. Stevens. (1997). Crystal structures of the free and liganded form of an esterolytic catalytic antibody 1 1Edited by I. A. Wilson. Journal of Molecular Biology. 268(2). 390–400. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathérine Ghezzi Breakdown of academic impact, for papers by Avgi Mamalaki Breakdown of academic impact, for papers by Michael M. Lai Breakdown of academic impact, for papers by Mikhail V. Ovanesov Breakdown of academic impact, for papers by John R. Adair Breakdown of academic impact, for papers by Katsuo Sugita Breakdown of academic impact, for papers by Takeshi Sugawara Breakdown of academic impact, for papers by Dong Soo Kang Breakdown of academic impact, for papers by Stephen M. Kaminsky Breakdown of academic impact, for papers by Pooja Naik
Rankless by CCL
2026